As the immunoblotting data here were reflections of the average EVA1C protein levels across all brain cell types, we asked whether changes of EVA1C levels occurred specifically in neurons across Braak stages in hippocampus, as well as in the entorhinal cortex [the first region of Tau pathology in AD; see review (6)]. Here, MAPT is linked to Alzheimer disease.